Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

The substantial biological heterogeneity of metastatic prostate cancer has hindered the development of personalized therapeutic approaches. Therefore, it is difficult to predict the course of metastatic hormone-sensitive prostate cancer (mHSPC), with some men remaining on first-line androgen depriva...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichert, Zachery R., Kasputis, Tadas, Nallandhighal, Srinivas, Abusamra, Sophia M., Kasputis, Amy, Haruray, Saloni, Wang, Yugang, Williams, Shamara, Singhal, Udit, Alva, Ajjai, Cackowski, Frank C., Caram, Megan E. V., Palmbos, Phillip L., Yentz, Sarah E., Smith, David C., Alumkal, Joshi J., Morgan, Todd M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744626/
https://www.ncbi.nlm.nih.gov/pubmed/35008431
http://dx.doi.org/10.3390/ijms23010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744626/
https://www.ncbi.nlm.nih.gov/pubmed/35008431
http://dx.doi.org/10.3390/ijms23010004

Ejemplares similares